MARY CHRISTIAN, PHARMD, MBA

SVP of Regulatory, C4 Therapeutics

​

Mary Christian, Pharm.D., MBA joined C4 Therapeutics in July 2023 as Senior Vice President, Regulatory. Previously, she served as Senior Vice President, Regulatory, Quality and Compliance at Lyndra Therapeutics.

 

Mary has more than 20 years of regulatory and drug development experience across pharmaceutical and biotechnology companies. Prior to her role at Lyndra Therapeutics, Mary served as Vice President, Global Quality, Regulatory, Safety & Development Outsourcing at Cyclerion Therapeutics following her role as Vice President, Head of Global Regulatory Affairs at Ironwood Pharmaceuticals, where she built a full service, global regulatory strategy team that oversaw expansion of commercial asset indications, labels and pediatric development and led asset transitions across clinical development and regulatory approvals.

 

Earlier in her career, Mary worked at Bristol-Myers Squibb in roles of increasing responsibility in regulatory and oncology strategic collaborations. She began her regulatory career at J&J Pharmaceutical Research & Development after more than 10 years serving patients in hospital and community pharmacy. She serves on the Scientific Advisory Boards of Promakhos Therapeutics and Syntis Bio.

 

Mary holds an MBA from University of the Sciences in Philadelphia, a Doctor of Pharmacy from University of Florida and a B.S. in pharmacy from Rutgers College of Pharmacy.

​